MicroRNA-9-1 Attenuates Influenza A Virus Replication via Targeting Tankyrase 1
Journal of Innate Immunity · 2023
DOI: 10.1159/000532063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Innate Immunity, 2023. Verfasst von Gayan Bamunuarachchi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Oklahoma Center for Respiratory and Infectious Diseases, Oklahoma State University, Stillwater, Oklahoma, USA. Hauptthemen laut MEDLINE: Influenza A virus, Influenza, Human, Interferon Type I, MicroRNAs. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, NHLBI NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
An unstable influenza genome leads to the virus resistance to antiviral drugs that target viral proteins. Thus, identification of host factors essential for virus replication may pave the way to develop novel antiviral therapies. In this study, we investigated the roles of the poly(ADP-ribose) polymerase enzyme, tankyrase 1 (TNKS1), and the endogenous small noncoding RNA, miR-9-1, in influenza A virus (IAV) infection. Increased expression of TNKS1 was observed in IAV-infected human lung epithelial cells and mouse lungs. TNKS1 knockdown by RNA interference repressed influenza viral replication. A screen using TNKS1 3′-untranslation region (3′-UTR) reporter assays and predicted microRNAs identified that miR-9-1 targeted TNKS1. Overexpression of miR-9-1 reduced influenza viral replication in lung epithelial cells as measured by viral mRNA and protein levels as well as virus production. miR-9-1 induced type I interferon production and enhanced the phosphorylation of STAT1 in cell culture. The ectopic expression of miR-9-1 in the lungs of mice by using an adenoviral viral vector enhanced type I interferon response, inhibited viral replication, and reduced susceptibility to IAV infection. Our results indicate that miR-9-1 is an anti-influenza microRNA that targets TNKS1 and enhances cellular antiviral state.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oklahoma Center for Respiratory and Infectious Diseases, Oklahoma State University, Stillwater, Oklahoma, USA.
- Lundberg-Kienlen Lung Biology and Toxicology Laboratory, Department of Physiological Sciences, Oklahoma State University, Stillwater, Oklahoma, USA.
Förderung
- NIGMS NIH HHS
- NHLBI NIH HHS
- NIAID NIH HHS
Zitieren
APA
Bamunuarachchi, G., Vaddadi, K., Yang, X., Dang, Q., Zhu, Z., Hewawasam, S., Huang, C., Liang, Y., Guo, Y., & Liu, L. (2023). MicroRNA-9-1 Attenuates Influenza A Virus Replication via Targeting Tankyrase 1. Journal of Innate Immunity. https://doi.org/10.1159/000532063
Vancouver
Bamunuarachchi G, Vaddadi K, Yang X, Dang Q, Zhu Z, Hewawasam S, et al. MicroRNA-9-1 Attenuates Influenza A Virus Replication via Targeting Tankyrase 1. Journal of Innate Immunity. 2023. doi:10.1159/000532063
BibTeX
@article{Bamunuarachchi2023,
author = {Bamunuarachchi, Gayan and Vaddadi, Kishore and Yang, Xiaoyun and Dang, Quanjin and Zhu, Zhengyu and Hewawasam, Sankha and Huang, Chaoqun and Liang, Yurong and Guo, Yujie and Liu, Lin},
title = {MicroRNA-9-1 Attenuates Influenza A Virus Replication via Targeting Tankyrase 1},
journal = {Journal of Innate Immunity},
year = {2023},
doi = {10.1159/000532063}
}
EUVIMED